Searchable abstracts of presentations at key conferences in endocrinology

ea0007p10 | Bone | BES2004

Inactivating progesterone metabolism in human osteoblasts

Kaur K , Cooper M , Arlt W , Stewart P , Hewison M , Quinkler M

The role of oestrogens and androgens on bone metabolism has been studied extensively. However, less is known about the effects of progestins. The progesterone receptor (PR) is expressed in human osteoblasts. Progestins have been found to stimulate osteoblast proliferation, differentiation and growth factor expression (e.g. IGFBP-5) and to increase bone formation. In postmenopausal women progestins combined with oestrogen increased bone density to a greater extent than oestroge...

ea0007p13 | Bone | BES2004

The role of local corticosteroid generation in inflammation-associated bone loss

Cooper M , Filer A , Moore J , Emery P , Buckley C , Hewison M , Stewart P

Generalised and periarticular osteoporosis are common features of inflammatory arthritides. These effects appear due to high levels of pro-inflammatory cytokines. 11beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1) is an intracellular enzyme that generates active cortisol from inactive cortisone and is an important determinant of the effects of glucocorticoids on osteoblasts. In vitro, osteoblastic 11b-HSD1 expression is induced by pro-inflammatory cytokines. We thus ...

ea0007p55 | Diabetes, metabolism and cardiovascular | BES2004

Expression of mineralocorticoid effector mechanisms in renal biopsies of patients with severe proteinuria

Quinkler M , Zehnder D , Lepenies J , Hughes S , Lipkin G , Hewison M , Stewart P

The role of 11beta-HSD2 is to provide selective access of aldosterone to the mineralocorticoid receptor (MR) by inactivating cortisol. Evidence suggests impaired 11beta-HSD2 activity in some patients with hypertension but also in patients with renal disease where it may contribute to sodium retention, oedema and hypertension. To date these studies have relied upon urinary cortisol metabolite analyses as markers of renal 11beta-HSD2 activity. We have directly analysed renal 11b...

ea0007p56 | Diabetes, metabolism and cardiovascular | BES2004

Testosterone regulates renal expression of the alpha-subunit of the epithelial sodium channel (alpha-ENaC)

Quinkler M , Bujalska I , Kaur K , Hughes S , Hewison M , Stewart P

Studies in rats suggest that androgens are involved in sex-specific differences in blood pressure. In human studies there is no difference in blood pressure between boys and girls, but following puberty, men present with a higher blood pressure than women. Modulation of sodium reabsorption through the ENaC is an important component in the control of sodium balance. This is clearly demonstrated by rare genetic disorders of sodium-channel activity (Liddle's syndrome and pseudohy...

ea0006oc28 | Neuroendocrinology | SFE2003

Safety And Efficacy Of Converting Patients With Acromegaly From Long-Acting Octreotide To Pegvisomant

Drake W , Rowles S , Paisley A , Stewart P , Monson J , Trainer P

We report the efficacy, safety, and effects on glucose homeostasis of converting patients with acromegaly from slow release octreotide (OT, treated for >3 months) to pegvisomant (Peg), a GH receptor antagonist. 52 patients (median age 49, range 23-81, 13 with diabetes) who had previously participated in a Peg clinical trial and subsequently treated with OT were enrolled in a 32-week, open-label, multicentre study. Peg 10 mg/d was started 4 weeks after the last dose of OT (w...

ea0006p69 | Steroids | SFE2003

REDUCED EXPRESSION OF 11BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 2 IN KIDNEY BIOPSIES OF PATIENTS WITH RENAL FAILURE

Quinkler M , Zehnder D , Lepenies J , Hughes S , Savage C , Hewison M , Stewart P

The role of 11beta-HSD2 is to provide selective access of aldosterone to the mineralocorticoid receptor by inactivating cortisol. Evidence suggests impaired 11beta-HSD2 activity in some patients with hypertension but also in patients with renal disease where it may contribute to sodium retention, oedema and hypertension. To date these studies have relied upon urinary cortisol metabolite analyses as markers of renal 11beta-HSD2 activity.We have directly a...

ea0005p23 | Clinical Case Reports | BES2003

Cushing's disease in adolescence

Dale J , McGregor E , Johnson A , Toogood A , Shaw N , Anderson J , Stewart P

A 16-year-old boy was referred to our endocrine unit. He had been diagnosed with constitutional short stature (height <10th centile) aged 11, having not grown well for two years. At that time there were no features to suggest Cushing's syndrome (CS), though he was overweight (BMI 22kg/m2, >90th centile) and bone age was delayed by 2 years. A trial of growth hormone (GH) therapy did not increase growth velocity. By age 15, he was developin...

ea0005p215 | Steroids | BES2003

11Beta-hydroxysteroid dehydrogenase in human fibroblasts: Expression and regulation depends on tissue of origin

Moore J , Filer A , Buckley C , Stewart P , Hewison M , Cooper M

Fibroblasts are important regulators of local inflammatory responses. These responses are further regulated by tissue glucocorticoid levels. Other stromal lineage cells, adipocytes and osteoblasts, express 11beta-hydroxysteroid dehydrogenases (11b-HSDs) which interconvert inactive cortisone and active cortisol. These enzymes are important regulators of local glucocorticoid levels and their expression is regulated by proinflammatory cytokines. We therefore examined expression o...

ea0005p236 | Steroids | BES2003

Regulation of the human 11beta-hydroxysteroid dehydrogenase gene by glucocorticoids

Bedendo O , Bujalska I , Draper N , Walker E , Hewison M , Mantero F , Stewart P

Glucocorticoids regulate transcription of many genes through the binding to the glucocorticoid receptor (GR) however, their intracellular levels are tightly regulated by the microsomal enzyme 11beta-hydroxysteroid dehydrogenase. Two isozymes of this enzyme have been cloned and characterised; 11beta- hydroxysteroid dehydrogenase type 1 (11beta-HSD1) which is mainly expressed in the liver and adipose tissue and 11beta-HSD type 2 expressed in the kidney and placenta. Within 2.5kb...